Beckley Psytech vs Reset Pharmaceuticals

Beckley Psytech logo

Beckley Psytech

Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions

28 employees · est. 2025 · Oxford, United States

VS
Reset Pharmaceuticals logo

Reset Pharmaceuticals

Advancing Novel Psychedelic Medicines to Improve Mental Health in Persons with Life-threatening Illness

2 employees · est. 2020

Reset Pharmaceuticals is the older company (2025 vs 2020); Beckley Psytech is the larger of the two.

Side-by-Side Comparison

Beckley Psytech Reset Pharmaceuticals
Founded
2025 2020 older
Headquarters
Oxford, United States Not tracked yet
Employees
28 larger 2
Industry
Not tracked yet Biotechnology, Health Care
Funding Stage
Merged Series A
Total Funding
$114.55M $11.10M
Funding Rounds
5 1
Services
Developing mental health treatments, Conducting clinical trials, Empathy-driven patient care Not tracked yet
Target Customers
Individuals with mental health conditions, Healthcare providers, Investors interested in mental health solutions Not tracked yet
Taxonomy
Psychedelic MedicineNeuropsychiatric DisordersClinical-stagePsilocybinDrug DevelopmentMental Health Treatment +7 PharmaceuticalsPsychedelic MedicineMental HealthCancer TreatmentDrug DevelopmentPsychotherapy +8
Website
ataibeckley.com resetpharma.com
Beckley Psytech logo

About Beckley Psytech

Beckley Psytech is a pioneering, clinical-stage biotechnology company founded in 2019 and headquartered in the United Kingdom. With a clear mission of "Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions," the company is focused on leveraging decades o...

Reset Pharmaceuticals logo

About Reset Pharmaceuticals

Reset Pharmaceuticals is a biotechnology startup founded in 2020, dedicated to advancing novel psychedelic medicines to improve mental health in individuals with life-threatening illnesses, particularly cancer. The company's lead program revolves around psilocybin in conjunction with psychotherapy,...

Also comparing in this category

Comparing more than these two?

Get Beckley Psytech, Reset Pharmaceuticals and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Beckley Psytech compare?

A PDF of Beckley Psytech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Beckley Psytech was founded in 2025, based in Oxford, United States, with 28 employees. Beckley Psytech is a pioneering, clinical-stage biotechnology company founded in 2019 and headquartered in the United Kingdom. With a clear mission of "Transforming psychedelics into effective and rap. Reset Pharmaceuticals was founded in 2020, with 2 employees. Reset Pharmaceuticals is a biotechnology startup founded in 2020, dedicated to advancing novel psychedelic medicines to improve mental health in individuals with life-threatening illnesses, particular.
Beckley Psytech has raised $114.55M and Reset Pharmaceuticals $11.10M. Latest stage: Beckley Psytech Merged, Reset Pharmaceuticals Series A.
Both list psychedelic medicine, psilocybin and drug development among their focus areas.

Compare Beckley Psytech with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Beckley Psytech on 9 Apr 2026, and Reset Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes